Results 111 to 120 of about 152,642 (298)

Chemotherapy in Uterine Mesenchymal Tumors

open access: yes, 2004
Comparison between single-agent and combination chemiotherapy against uterine mesenchymal tumors. Doxorubicine for LMS and ifosfamide and cisplatin for MMT are the most effective antineoplastic drugs in single-agent chemiotherapy.
Donadello N   +2 more
core  

Nitrogen‐Based Bisphosphonate Use and Risk of Cancer in Women Aged 50 Years and Older: A National Data Linkage Study

open access: yesInternational Journal of Cancer, EarlyView.
Bisphosphonates are widely used to treat osteoporosis and to manage bone metastases in patients with breast cancer. Nitrogen‐based bisphosphonates may also broadly reduce cancer risk, but evidence remains inconsistent. This large population‐based data linkage study in women aged > 50 years found that, compared to no use of osteoporosis medicines ...
Karen M. Tuesley   +7 more
wiley   +1 more source

Uterine Tumors Resembling Ovarian Sex Cord Tumors in Four Baboons (Papio spp.)

open access: yes, 2018
Uterine tumors resembling ovarian sex cord tumors (UTROSCTs) are rare uterine neoplasms that exhibit prominent sex cord-like differentiation. The authors describe 4 cases of UTROSCTs that were identified as incidental lesions in female baboons.
Edward J. Dick   +6 more
core   +1 more source

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany

open access: yesInternational Journal of Cancer, EarlyView.
Molecular tumor boards (MTB), interdisciplinary teams that use tumor genomic data to guide personalized treatment decisions, have emerged as a promising strategy in melanoma care, although their real‐world clinical impact remains uncertain. This retrospective study evaluated advanced melanoma patients to assess molecularly guided treatment ...
Glenn Geidel   +26 more
wiley   +1 more source

A personalized approach to the surgical treatment of early-stage uterine body cancer with tumor involvement in the lower uterine segment. Clinical observation

open access: yesКлинический разбор в общей медицине
In the Russian Federation, the incidence of uterine body cancer remains the highest among malignant neoplasms of the female genital organs. Surgical treatment is the primary method for treating early stages of the disease; however, the issue of ...
Borislav E. Tkachenko   +8 more
doaj   +1 more source

DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics. [PDF]

open access: yesJ Cancer Res Clin Oncol, 2020
Kommoss FKF   +24 more
europepmc   +1 more source

Uterine lipoleiomyoma: rare presentation of postmenopausal bleeding

open access: yes
Uterine lipoleiomyomas are rare benign tumors composed of mature adipose tissue and smooth muscle cells. They account for less than 0.2% of all uterine neoplasms and are typically asymptomatic, often discovered incidentally.
Sahay, Vinita, Sahay, Nehal
core   +1 more source

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley   +8 more
wiley   +1 more source

Recurrent uterine adenofibroma revealed to be hyperparathyroidism–jaw tumor syndrome: Case report

open access: yesRadiology Case Reports
Uterine adenofibroma was previously classified as a benign mixed epithelial and mesenchymal tumor, but the WHO removed it from its fifth edition due to diagnostic overlap with low-grade adenosarcoma or benign polyps.
Go Nakai, MD, PhD   +4 more
doaj   +1 more source

Cervical screening in Australia 2012–2013 [PDF]

open access: yes, 2015
Presents the latest national statistics monitoring the National Cervical Screening Program, which aims to reduce incidence, morbidity and mortality from cervical cancer.
Australian Institute of Health and Welfare
core  

Home - About - Disclaimer - Privacy